<DOC>
	<DOCNO>NCT00341783</DOCNO>
	<brief_summary>There 300-500 million case malaria worldwide year , 2-3 million death . Plasmodium falciparum , one four type malaria , responsible death . Because increase resistance parasite drug mosquito insecticide , vaccine would valuable fight malaria . Don gu bougou , Mali , area seasonal malaria transmission investigate possible suitable site test investigational malaria vaccine . The goal study characterize population site term common hematologic ( blood ) biochemistry parameter may use determine eligibility participation vaccine trial . The study also assess prevalence preexist medical condition might affect assessment vaccine safety efficacy . Also , natural immunity antigens investigational malaria vaccine determine . Don gu bougou , Mali , choose high malaria rate . Data collect four time-points . At least 50 individual recruit follow age group : 6 months-5 year ; 6-10 year ; 11-15 year ; 16-45 year . Village-wide consent obtain 25 111 family compound randomly select . Individual consent also obtain . Enrolled volunteer undergo baseline medical history physical examination . Blood collect various test , , woman childbearing age , urine pregnancy test administer . At three followup visit , brief medical history physical exam conduct . Blood drawn test . Also , blood , urine , and/or stool test do baseline do one followup visit .</brief_summary>
	<brief_title>Assessment Biologic Parameters Preparation Future Malaria Vaccine Trials Don gu Bougou , Mali</brief_title>
	<detailed_description>Doneguebougou , Mali , area seasonal malaria transmission investigate suitable site test investigational malaria vaccine . The overall goal study characterize population site term common hematologic biochemistry parameter may use determine eligibility participation vaccine trial , well term preexist medical condition preexist immunity potential malaria vaccine antigen , might impact assessment vaccine safety efficacy . The development high quality laboratory proficiency ass parameter Mali also achieve study .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<criteria>INCLUSION CRITERIA : Males female age 6 month 45 year . Resident Doneguebougou start study , intent remain resident duration study . Willingness participate study evidence complete informed consent document . EXCLUSION CRITERIA : Clinical evidence acute lifethreatening illness require immediate medical care .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2005</verification_date>
	<keyword>Plasmodium</keyword>
	<keyword>Falciparum</keyword>
	<keyword>Screening</keyword>
	<keyword>Malaria</keyword>
</DOC>